U.S. Healthtech Stock News

NasdaqGS:RGNX
NasdaqGS:RGNXBiotechs

Regenxbio (RGNX) Q1 Loss Deepens And Reinforces Bearish Cash Runway Concerns

REGENXBIO (RGNX) Q1 2026 earnings snapshot REGENXBIO (RGNX) has just posted Q1 2026 results with revenue of US$6.4 million and a basic EPS loss of US$1.72, against a trailing twelve month basic EPS loss of US$5.59 on revenue of US$87.8 million. Over recent quarters the company has reported revenue of US$89.0 million in Q1 2025, followed by US$21.4 million in Q4 2024. Basic EPS moved from a profit of US$0.12 in Q1 2025 to a loss of US$1.01 in Q4 2024. These figures are likely to draw investor...
NYSE:LEG
NYSE:LEGConsumer Durables

Leggett & Platt (LEG) Is Down 8.0% After Q1 2026 Sales and Profit Decline - What's Changed

Leggett & Platt, Incorporated has reported past first-quarter 2026 results showing sales of US$918.2 million, down from US$1,022.1 million a year earlier, with net income falling from US$30.6 million to US$20 million. The simultaneous decline in both revenue and profitability gives investors a fresh data point on how the company is managing current demand conditions and cost pressures. We’ll now examine how this quarter’s weaker sales and earnings reshape Leggett & Platt’s investment...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Nebius Group (NBIS) Q1 Profitability Surge Tests Justification For Rich 77x P/E

Nebius Group (NasdaqGS:NBIS) has opened 2026 with Q1 revenue of US$399 million and Basic EPS of US$2.40, alongside net income of US$621.2 million, setting a clear marker after a volatile run of prior quarters. The company has seen revenue move from US$55.3 million in Q1 2025 and US$35.2 million in Q4 2024 to US$399 million in Q1 2026, with Basic EPS shifting from a loss of US$0.48 in Q1 2025 and a loss of US$0.58 in Q4 2024 to a profit of US$2.40. This puts the focus firmly on how sustainable...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

New Cooper Companies Director Adds Oversight As Shares Trade Below Targets

Cooper Companies (NasdaqGS:COO) has appointed Paul Keel to its Board of Directors. Keel will also serve on the Board’s Audit Committee. The appointment brings experience from senior executive roles at major medical technology and industrial companies. For investors watching Cooper Companies at a share price of $60.38, this board change comes after a period of weak stock performance. The stock is down 15.7% over the past 30 days, 25.6% year to date, and 25.9% over the past year, with a 37.9%...
NasdaqCM:SSII
NasdaqCM:SSIIMedical Equipment

SS Innovations International (SSII) Losses Challenge Bullish Narratives After Q1 2026 Results

SS Innovations International (NasdaqCM:SSII) opened 2026 with Q1 revenue of about US$11.1 million and a basic EPS loss of US$0.02, while trailing 12 month figures show revenue of roughly US$48.5 million and a basic EPS loss of US$0.05. Over the past reported quarters, revenue has ranged from about US$5.1 million in Q1 2025 to US$14.5 million in Q4 2025, with basic EPS losses moving between roughly US$0.00 and US$0.03 per share. Investors are therefore likely to focus on how efficiently that...
NYSE:BHVN
NYSE:BHVNBiotechs

Biohaven (BHVN) Narrows Loss and Adds Shelf Registration Is Its Capital Strategy Evolving?

Biohaven Ltd. reported first-quarter 2026 results in the past, narrowing its net loss to US$130.53 million from US$221.68 million a year earlier, while loss per share from continuing operations declined to US$0.88 from US$2.17. On the same day, Biohaven filed an omnibus shelf registration covering a wide range of securities, potentially giving the company considerable flexibility in how it may access capital in the future. With these earnings and the broad shelf registration in mind, we’ll...
NYSE:RAMP
NYSE:RAMPSoftware

Valpak Data Integration Could Be A Game Changer For LiveRamp Holdings (RAMP)

In May 2026, Valpak Intelligence announced that its New Mover and New Business audience segments became directly available in LiveRamp’s Data Marketplace, giving marketers, brands, and agencies streamlined access to its postal-anchored identity data across major DSPs, SSPs, CTV platforms, and CRM destinations without separate licensing agreements. This partnership brings Valpak’s decades-built household identity spine, spanning approximately 135 million households and hundreds of millions of...
NasdaqGM:KROS
NasdaqGM:KROSBiotechs

Keros Therapeutics (KROS) Revenue Collapse To US$0.4 Million Challenges Bullish Growth Narratives

Keros Therapeutics (KROS) has just posted Q1 2026 results, with revenue of US$0.4 million, a basic EPS loss of US$1.21 and a net loss of US$23.7 million, setting the tone for the quarter at a share price of US$10.99. The company has seen quarterly revenue move from US$211.2 million in Q1 2025 to US$0.4 million in Q1 2026, while basic EPS shifted from a profit of US$3.66 to a loss of US$1.21. This puts the spotlight on how changes in revenue expectations and potential margin developments could...
OTCPK:DIDI.Y
OTCPK:DIDI.YTransportation

DiDi Global (OTCPK:DIDI.Y) Valuation Check As Robotaxi Push Expands In Beijing And UAE

Robotaxi expansion puts DiDi Global (DIDI.Y) in focus DiDi Global (DIDI.Y) is drawing attention after moving faster on autonomous driving, securing a road test license in Beijing for its latest robotaxi and preparing pilot programs in the UAE. See our latest analysis for DiDi Global. Despite the robotaxi progress, recent momentum has been weak. The share price is US$3.58 with a year to date share price return down 35.61%, while the 3 year total shareholder return is 12.23%, hinting at a mixed...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

Texas Instruments (TXN) Is Up 8.0% After Strong Q1 AI Data Center-Driven Beat Is Reported

In recent days, Texas Instruments reported better-than-expected first-quarter results, highlighting strong analog revenue growth powered by industrial demand and a sharp rise in AI data center-related sales, while sector-wide optimism around semiconductors has been reinforced by broader index gains and supportive earnings across many chipmakers. At the same time, management’s emphasis on analog and embedded processing strengths, expanding internal manufacturing capacity, and upcoming...
NasdaqGS:VSNT
NasdaqGS:VSNTMedia

Versant Media Group (VSNT) Margin Compression Reinforces Bearish Profitability Narratives

Versant Media Group (VSNT) opened Q1 2026 with revenue of US$1.7 billion and basic EPS of US$1.99, setting the tone for how investors will weigh the latest move in profitability. Over recent periods the company has seen quarterly revenue move from US$1.7 billion in Q1 2025 to US$1.6 billion in Q4 2025 and then to US$1.7 billion in Q1 2026, while net income excluding extra items shifted from US$334.5 million to US$181 million and then to US$286 million, giving a clear read on how earnings...
NYSE:STE
NYSE:STEMedical Equipment

How Investors May Respond To STERIS (STE) Record FY26 Results And US$1 Billion Buyback Plan

Earlier this week, STERIS plc reported its fourth-quarter and fiscal 2026 results, with full-year sales of US$5,935.9 million and net income of US$782.3 million, alongside new fiscal 2027 guidance calling for 7%–8% reported revenue growth and a fresh US$1.00 billion share repurchase authorization. Management paired record annual revenue and earnings per share with plans for substantial buybacks and elevated capital spending, signaling confidence in the durability of demand for its infection...
NasdaqGS:KLIC
NasdaqGS:KLICSemiconductor

Why Kulicke and Soffa (KLIC) Is Up 6.1% After AI-Focused Thermo-Compression Capacity Expansion Plan

Kulicke and Soffa Industries recently reported fiscal second-quarter 2026 results, with sales rising to US$242.62 million and net income improving to US$35.15 million, a shift from a net loss a year earlier. Alongside the earnings rebound, the company outlined plans to increase capital spending to expand thermo-compression bonding capacity for advanced packaging used in AI and high-performance chips. We’ll now examine how this earnings improvement and stepped-up thermo-compression investment...
NYSE:WWW
NYSE:WWWLuxury

Wolverine World Wide (WWW) Margin Improvement Reinforces Bullish Profitability Narrative

Wolverine World Wide (WWW) opened Q1 2026 with revenue of US$457.6 million and basic EPS of US$0.25, against a current share price of US$15.22. This sets a clear marker for how its latest quarter feeds into a steadily building earnings profile. The company has seen quarterly revenue move from US$412.3 million and EPS of US$0.13 in Q1 2025 to US$457.6 million and EPS of US$0.25 in Q1 2026. Trailing twelve month EPS stands at US$1.24 on revenue of roughly US$1.9 billion, giving investors a...
NYSE:ROL
NYSE:ROLCommercial Services

Will Rollins' (ROL) Pricing Focus and Pest Trends Reinforce or Recast Its Long-Term Narrative?

Earlier this month, Rollins, Inc. held an Analyst/Investor Day where, according to RBC Capital Markets, the company was expected to reaffirm its 2026 and medium-term outlook, emphasizing its pricing approach and operational efficiency. Meanwhile, Orkin Canada, a Rollins subsidiary, highlighted seasonal carpenter ant risks and shared practical prevention guidance, underscoring how pest trends can support demand for the group’s services. We’ll now examine how Rollins’ confidence in its...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Capital Southwest (CSWC) Earnings Growth And 48.7% Margin Challenge Dividend Risk Concerns

Capital Southwest (CSWC) closed FY 2026 with fourth quarter revenue of US$57.8 million and basic EPS of US$0.48, set against trailing 12 month revenue of US$232.1 million and EPS of US$2.00. Over recent periods, the company has seen revenue range from US$52.4 million in FY 2025 Q4 to US$61.4 million in FY 2026 Q3, with quarterly EPS moving between US$0.33 and US$0.57 over the same span, while trailing net profit margin reached 48.7% and earnings growth over the past year was 61.7%. For...
NYSE:MWA
NYSE:MWAMachinery

Assessing Mueller Water Products (MWA) Valuation After Recent Share Price Volatility

Recent share performance and business mix Mueller Water Products (MWA) has been drawing investor attention after its stock rose 1.7% over the past day, even as returns over the past month and past 3 months declined 14.3% and 14.2% respectively. The company operates across two main segments: Water Flow Solutions and Water Management Solutions. It generates revenue of $1.46b and net income of $207.4m, with annual revenue growth of 3.3% and net income growth of 10.0%. See our latest analysis for...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

Nova (NVMI) Net Margin Expansion Tests Bullish Longer Term Narratives

Q1 2026: Setting the Scene for Nova (NasdaqGS:NVMI) Nova (NasdaqGS:NVMI) has opened 2026 with Q1 revenue of US$235.3 million and basic EPS of US$2.18, building on a trailing twelve month picture of US$902.5 million in revenue and basic EPS of US$8.58. Over the past year, revenue has moved from US$213.4 million in Q1 2025 to US$235.3 million in Q1 2026, while basic EPS has shifted from US$2.22 to US$2.18. This sets up a quarter where investors are likely to focus squarely on how the company is...
NasdaqGS:IQ
NasdaqGS:IQEntertainment

Will Overseas Revenue Records and AI Push Change iQIYI's (IQ) Long-Term Narrative?

Recently, iQIYI reported a very large year-over-year increase in content distribution revenue and record overseas revenue, underpinned by US$639.6 million in cash and a push into AI-powered content and international markets. At the same time, a series of insider filings showed management reshaping long-dated stock option incentives without open-market trading, highlighting a focus on long-term alignment rather than near-term ownership changes. We’ll now examine how this surge in content...
NYSE:BNT
NYSE:BNTInsurance

Brookfield Wealth Solutions (BNT) Q1 Loss And Margin Compression Challenge Bullish Earnings Narrative

Brookfield Wealth Solutions (BNT) has opened 2026 with a mixed Q1 print, reporting revenue of US$1.7b and a loss per share of US$1.83 on net income of US$609m. Over the last few quarters, revenue has moved from US$2.6b in Q1 2025 to US$3.1b in Q4 2025 before landing at US$1.7b in Q1 2026. Basic EPS has swung from a loss of US$0.90 to a profit of US$1.89 and US$1.18, then just US$0.02 ahead of the latest quarterly loss. With trailing 12 month EPS of US$1.45 and a net profit margin that has...
NYSE:OSK
NYSE:OSKMachinery

Are Oshkosh’s (OSK) Tariff Refunds And Dividend Policy Masking Deeper Earnings Trade-Offs?

Oshkosh Corporation recently reported that first-quarter 2026 sales were US$2,317.8 million with net income of US$43.1 million, maintained its full-year diluted EPS guidance at US$10.90, confirmed receiving initial tariff refund checks, held its annual shareholder meeting where a voting proposal was rejected, and declared a quarterly dividend of US$0.57 per share paid in June 2026. Investors now have to weigh how the early tariff refunds and ongoing dividend payments interact with weaker...
NYSEAM:NINE
NYSEAM:NINEEnergy Services

Nine Energy Service (NINE) Profit Swing To US$1.95 EPS Tests Cash Flow Bear Thesis

Nine Energy Service (NINE) has put up a sharp swing into profit in Q1 2026, with revenue of US$130.0 million and net income of US$106.6 million translating into basic EPS of US$1.95 for the quarter. Over the past five quarters, revenue has moved from US$150.5 million in Q1 2025 through a range of US$132.2 million to US$147.3 million, while EPS has shifted from a loss of US$0.18 per share in Q1 2025 to a profit of US$1.95 in Q1 2026. This sets up a story where margins rather than top line are...
NasdaqGM:ASTL
NasdaqGM:ASTLMetals and Mining

Algoma Steel Group Q1 Loss Narrows Yet Deep Trailing Losses Challenge Bullish Narratives

Algoma Steel Group’s Q1 2026 Results: Revenue Slides While Losses Narrow Algoma Steel Group (NasdaqGM:ASTL) opened fiscal 2026 with Q1 revenue of C$296.9 million and a basic EPS loss of C$1.46 per share, compared with a loss of C$0.61 per share in Q4 2024 on revenue of C$590.3 million. Over the past year, quarterly revenue has moved from C$517.1 million in Q1 2025 to C$296.9 million in Q1 2026, while net losses widened from C$24.5 million to C$159.4 million, setting a tough backdrop for the...
NasdaqCM:MDXH
NasdaqCM:MDXHBiotechs

MDxHealth (MDXH) Q1 Loss Near US$8.9 Million Reinforces Bearish Profitability Concerns

MDxHealth (NasdaqCM:MDXH) opened Q1 2026 with revenue of US$27.4 million and a basic EPS loss of US$0.17, alongside trailing 12 month revenue of US$111.0 million and a cumulative net loss of US$33.2 million that keeps the focus firmly on profitability. Over the last year, the company has seen revenue move from US$24.7 million in Q4 2024 to US$27.4 million in Q1 2026, while quarterly EPS has stayed in a tight range between a loss of US$0.14 and US$0.19, highlighting a situation where top line...